Please assess the completion status of the following clinical trial:

Trial Title: Augmented Multimodal Neurologic Monitoring in High Risk Survivors of Cardiac Arrest

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* High risk survivors of cardiac arrest~* Decision by potential subject's clinical team to use our institutional standard invasive, multimodal neurologic monitoring for post-arrest care~Exclusion Criteria:~* None

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cardiac arrest (Type: EXPERIMENTAL): Survivors of cardiac arrest at high risk of neurological deterioration. Participants will undergo placement of a Spencer Probe Depth Electrode and QFlow 500™ Perfusion Probe in addition to the institutional standard multimodal neurological monitoring.

Based on this trial design, predict the completion outcome and termination type (if applicable).